Your browser doesn't support javascript.
loading
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
Baselga, José; Zamagni, Claudio; Gómez, Patricia; Bermejo, Begoña; Nagai, Shigenori E; Melichar, Bohuslav; Chan, Arlene; Mángel, Lászlo; Bergh, Jonas; Costa, Frederico; Gómez, Henry L; Gradishar, William J; Hudis, Clifford A; Rapoport, Bernardo L; Roché, Henri; Maeda, Patricia; Huang, Liping; Meinhardt, Gerold; Zhang, Joshua; Schwartzberg, Lee S.
Afiliação
  • Baselga J; Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: baselgaj@mskcc.org.
  • Zamagni C; S. Orsola Malpighi Hospital, Bologna, Italy.
  • Gómez P; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Bermejo B; Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Nagai SE; Saitama Cancer Center, Saitama, Japan.
  • Melichar B; Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.
  • Chan A; Curtin Health Innovation Research Institute, Curtin University, Perth, Australia.
  • Mángel L; University of Pécs, Pécs, Hungary.
  • Bergh J; Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Costa F; Hospital Sírio Libanês, São Paulo, Brazil.
  • Gómez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • Gradishar WJ; Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Hudis CA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Rapoport BL; The Medical Oncology Center of Rosebank and Linksfield Park Hospital, Johannesburg, South Africa.
  • Roché H; Institut Claudius Régaud, Toulouse, France.
  • Maeda P; Bayer HealthCare Pharmaceuticals, Whippany, NJ.
  • Huang L; Bayer HealthCare Pharmaceuticals, Whippany, NJ.
  • Meinhardt G; Bayer HealthCare Pharmaceuticals, Whippany, NJ.
  • Zhang J; Bayer HealthCare Pharmaceuticals, Whippany, NJ.
  • Schwartzberg LS; The West Clinic, Memphis, TN.
Clin Breast Cancer ; 17(8): 585-594.e4, 2017 12.
Article em En | MEDLINE | ID: mdl-28830796
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Niacinamida / Capecitabina Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Niacinamida / Capecitabina Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article